** = Publikationen gelistet in SCI/SSCI/Pubmed
** Pieber, TR; Arfelt, KN; Cailleteau, R; Thomsen, KMD; Hart, M; Mursic, I; Svehlikova, E; Urschitz, M; Haahr, H
Hypoglycaemia frequency and physiological response to double or triple doses of once-weekly insulin icodec versus once-daily insulin glargine in type 2 diabetes
DIABETOLOGIA. 2022; 65(SUPPL 1):S333-S333.-58th Annual Meeting of the European Association for the Study of Diabetes; Sep 20-23, 2022; Stockholm.
[Oral Communication]
Web of Science
** Svehlikova, E; Hoeller, V; Urschitz, M; Wolf, M; Lackner, B; Magnes, C; Ratzer, M; Gerring, D; Jezek, J; Howell, SJ; Zakrzewski, L; Pillai, V; Ashcroft, N; Lawrence, F; Pieber, TR
Phase I study investigating PK and PD of highly concentrated insulin aspart AT278 U500
DIABETOLOGIA. 2022; 65(SUPPL 1):S209-S210.-58th EASD Annual Meeting; Sep 19-23, 2022; Stockholm, Sweden.
[Poster]
Web of Science
** Svehlikova, E; Holler, V; Gumilar, J; Fluhr, G; Urschitz, M; Wolf, M; Lackner, B; Magnes, C; Ratzer, M; Gerring, DJ; Jezek, J; Howell, SJ; Zakrzewski, L; Pillai, V; Ashcroft, N; Lawrence, FJ; Pieber, TR
Phase I study investigating PK and -PD of highly-concentrated insulin aspart AT278 U500
WIEN KLIN WOCHENSCHR. 2022; 134(SUPPL 4):262-262.
[Oral Communication]
Web of Science
** Svehlikova, E; Holler, V; Urschitz, M; Wolf, M; Lackner, B; Magnes, C; Ratzer, M; Gerring, D; Jezek, J; Howell, S; Zakrzewski, L; Pillai, V; Ashcroft, N; Lawrence, F; Pieber, T
AT278 (U500) - PK/PD AND SAFETY OF RAPID-ACTING CONCENTRATED INSULIN ASPART
DIABETES TECHNOL THE. 2022; 24: A39-A40.-ATTD 2022 ; APR 27-30, 2022; Barcelona, Spain.
[Oral Communication]
Web of Science
** Svehlikova, E; Mursic, I; Augustin, T; Magnes, C; Gerring, D; Jezek, J; Schwarzenbacher, D; Ratzer, M; Wolf, M; Howell, S; Zakrzewski, L; Urschitz, M; Tschapeller, B; Gatschelhofer, C; Feichtner, F; Lawrence, F; Pieber, TR
Pharmacokinetics and Pharmacodynamics of Three Different Formulations of Insulin Aspart: A Randomized, Double-Blind, Crossover Study in Men With Type 1 Diabetes.
Diabetes Care. 2021; 44(2):448-455
Doi: 10.2337/dc20-1017
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Mursic, I; Svehlikova, E; Regittnig, W; Urschitz, M; Wolf, M; Brunner, M; Augustin, T; Magnes, C; Eberl, A; Heise, T; Klein, O; Sourij, H; Pieber, T
Acid-base changes during diabetic ketoacidosis in type 1 diabetes with/without SGLT2 inhibitor.
DIABETOLOGIA. 2020; 63(SUPPL 1):S272-S273.-56th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); SEP 21-25, 2020; ELECTR NETWORK.
[Oral Communication]
Web of Science
** Regittnig, W; Urschitz, M; Lehki, B; Wolf, M; Kojzar, H; Mader, JK; Ellmerer, M; Pieber, TR
Insulin Bolus Administration in Insulin Pump Therapy: Effect of Bolus Delivery Speed on Insulin Absorption from Subcutaneous Tissue.
Diabetes Technol Ther. 2019; 21(1): 44-50.
Doi: 10.1089/dia.2018.0295
Web of Science
PubMed
FullText
FullText_MUG
** Svehlikova, E; Sach-Friedl, S; Schadler, HP; Augustin, T; Magnes, C; Eberl, A; Narath, S; Urschitz, M; Wolf, M; Treiber, G; Pieber, TR
A novel stepwise eu-, hyper- and hypoglycaemic clamp using stable tracer method to compare glucose fluxes and lipolysis in type 1 and type 2 diabetes
DIABETOLOGIA. 2017; 60: S115-S116.-53rd Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); SEP 11-15, 2017; Lisbon, PORTUGAL.
[Oral Communication]
Web of Science
** Zenz, S; Regittnig, W; Urschitz, M; Brunner, M; Korsatko, S; Raml, R; Narath, S; Magnes, C; Tschapeller, B; Augustin, T; Pieber, TR
Endogenous Glucose Production during an induced Hypoglycemia in newly diagnosed and long term Type 1 Diabetes
WIEN KLIN WOCHENSCHR. 2015; 127: S136-S136.
[Oral Communication]
Web of Science
** Korsatko, S; Deller, S; Mader, JK; Glettler, K; Koehler, G; Treiber, G; Urschitz, M; Wolf, M; Hastrup, H; Søndergaard, F; Haahr, H; Pieber, TR
Ultra-long pharmacokinetic properties of insulin degludec are comparable in elderly subjects and younger adults with type 1 diabetes mellitus.
Drugs Aging. 2014; 31(1):47-53
Doi: 10.1007/s40266-013-0138-0
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Deller, S; Neubauer, K; Korsatko, S; Wolf, M; Urschitz, M; Zahiragic, S; Mader, J; Adrian, C; Thomsen, H; Haahr, H; Pieber, T
Ultra-Long-acting insulin Degludec: Two different concentrations (U100 and U200) showing bioequivalence and comparable pharmacodynamics
WIEN KLIN WOCHENSCHR. . 2011; 123: S10-S11.-39. Jahrestagung der Österreichischen Diabetes Gesellschaft; NOV 17-19, 2011; Salzburg, AUSTRIA.
[Oral Communication]
Web of Science
** Mader, J; Lucarelli, F; Scuffi, C; Friedrich, S; Korsatko, S; Urschitz, M; Wolf, M; Ellmerer, M; Valgimigli, F; Pieber, T
Evaluate the safety and accuracy of GlucoMen (R) Day system for continuous subcutaneous glucose monitoring in patients with Type 1 diabetes
WIEN KLIN WOCHENSCHR. . 2011; 123: S5-S5.-39. Jahrestagung der Österreichischen Diabetes Gesellschaft; NOV 17-19, 2011; Salzburg, AUSTRIA.
[Oral Communication]
Web of Science
** Bock, G; Mader, J; Prietl, B; Fruhmann, J; Urschitz, M; Hueter, N; Obermayer-Pietsch, B; Pieber, T
Placebo-controlled trial to investigate dan effects of vitamin D substitution on the glucose metabolism in healthy subjects.
WIEN KLIN WOCHENSCHR. 2010; 122: S5-S5.-ÖDG;
[Oral Communication]
Web of Science